Inspire Medical Systems (INSP) was downgraded by Zacks Research from "strong-buy" to "hold".
Inspire Medical Systems (INSP) had its price target lowered by Truist Financial Corporation from $70.00 to $64.00. They now have a "hold" rating on the stock.
Inspire Medical Systems (INSP) had its "sector perform" rating reaffirmed by Royal Bank Of Canada.
Inspire Medical Systems (INSP) was given a new $70.00 price target by Mizuho.
Inspire Medical Systems (INSP) had its price target lowered by Stifel Nicolaus from $85.00 to $70.00. They now have a "buy" rating on the stock.